---
title: "Berkshire Hathaway's Latest Portfolio Changes (Q2 2025)"
author: "DeepValues Research"
publisher: "DeepValues Research (DeepValues / LuLu Ventures LLC)"
type: "Research article"
date: "2026-02-19"
language: "en"
section: "Business Notes"
answer: "DeepValues Research, “Berkshire Hathaway's Latest Portfolio Changes (Q2 2025)” (Feb 19, 2026): The latest Berkshire portfolio moves highlight Buffett's unwavering commitment to value and quality."
canonical_url: "https://research.deepvalues.ai/business/berkshire-hathaways-latest-portfolio-changes-q2-2025/"
markdown_url: "https://research.deepvalues.ai/business/berkshire-hathaways-latest-portfolio-changes-q2-2025/index.md"
license: "CC BY 4.0"
license_url: "https://creativecommons.org/licenses/by/4.0/"
cite_as: "DeepValues Research, Berkshire Hathaway's Latest Portfolio Changes (Q2 2025), https://research.deepvalues.ai/business/berkshire-hathaways-latest-portfolio-changes-q2-2025/"
publisher_url: "https://deepvalues.ai"
app: "https://deepvalues.ai"
api: "https://app.deepvalues.ai/developers"
data_note: "Reports are dated snapshots. Current data via the DeepValues API: https://app.deepvalues.ai/developers"
disclaimer: "Educational research, not investment advice."
---
# **Berkshire Hathaway's Latest Portfolio Changes (Q2 2025)**

Berkshire Hathaway's **Q2 2025 13F filing** (released mid-August 2025) revealed several notable portfolio moves . Warren Buffett and his team made **six new stock investments**, added to a few existing positions, and trimmed or exited some holdings. Below is a detailed rundown of **every change** and its significance relative to Berkshire's \~$257.5 billion equity portfolio:

-   **New Positions Added:** Berkshire took **six new stakes** in Q2 2025 , targeting housing, industrials, and healthcare sectors. These new buys are relatively small (together &lt;2% of the portfolio) but signal Buffett's focus on value opportunities:

    -   **Lennar Corp (LEN) - 7.05 million Class A shares.** A major U.S. homebuilder, this stake was worth \~$950 million (≈0.4% of the portfolio) at quarter-end . Lennar operates in residential construction, a sector Buffett historically avoided during frothy periods but now finds attractively valued (Lennar's P/E was in single digits - more on valuation below).

    -   **Nucor Corp (NUE) - 6.61 million shares.** A leading steelmaker, new stake worth \~$857 million (\~0.33% of the portfolio) . This bet on industrial commodities suggests Buffett sees **undervalued cyclicals** in an uncertain economy. Nucor's low earnings multiple and strong balance sheet likely appealed to Berkshire.

    -   **UnitedHealth Group (UNH) - 5.04 million shares.** Berkshire's **first foray into a major health insurer**, valued about $1.4-1.5 billion (\~0.6% of the portfolio) . UnitedHealth's stock jumped on the disclosure , indicating the market's surprise at Buffett's confidence in this blue-chip healthcare franchise.

    -   **D.R. Horton (DHI) - 1.49 million shares.** Another homebuilder added alongside Lennar, worth \~$250-$260 million (\~0.1% of holdings) . Buffett is clearly **bullish on U.S. housing**, as D.R. Horton is the nation's largest builder - Berkshire likely views its low P/E and robust demand backlog as a margin-of-safety play.

    -   **Lamar Advertising (LAMR) - 1.17 million shares.** A niche pick worth \~$142 million , Lamar is a billboard/outdoor advertising REIT. This **"niche but resilient"** business (as one report described) provides steady cash flows . Its addition hints that Buffett (or his portfolio managers) see value in high-yield infrastructure-like assets amid high interest rates.

    -   **Allegion PLC (ALLE) - 0.78 million shares.** A \~$112 million stake in a global provider of locks and security systems. This is a **small bet on a durable, old-economy business** with stable demand (commercial and residential security products). Allegion's relatively modest valuation and cash generation likely fit Buffett's criteria for a quality business at a fair price.

-   **Additions to Existing Holdings:** Berkshire **increased several recent investments**, doubling down on companies purchased in prior quarters . Notable Q2 add-ons:

    -   **Pool Corp (POOL) - +136%** increase. Berkshire more than **doubled its Pool Corp stake**, raising it to \~3.46 million shares (worth \~$1.0 billion) from \~1.46 million . Pool is a distributor of swimming pool supplies and equipment. This aggressive add signals **strong conviction** - Pool is one of Berkshire's newest holdings (initiated in Q1 2025) and now a sizable \~$1B position.

    -   **Lennar Corp Class B - +19%.** In addition to the new Class A position, Berkshire modestly increased its **Lennar Class B shares** by 19% (to \~181K shares ). This mirrors the bullish stance on housing.

    -   **Constellation Brands (STZ) - +12%.** Berkshire added \~12% more to its stake in Constellation (owner of Corona beer, wines, spirits) . Berkshire already held \~12.6-13.4 million shares of STZ (a \~$2+ billion stake) and increased it further. This signals **ongoing confidence in the beverage business**, perhaps viewing the stock as undervalued after earlier market turbulence.

    -   **Heico Corp (HEI) - +11%.** Berkshire boosted its holding in Heico (an aviation/aerospace components manufacturer) by \~11% to 1.29 million shares . Heico is a high-quality, high-P/E company; the add-on suggests Berkshire sees long-term value despite its premium valuation.

    -   **Chevron (CVX) - +3%.** Berkshire made a small increase to its Chevron stake , even as it has trimmed other stocks. Oil prices had been relatively weak, and Buffett may have taken the opportunity to **average up**slightly on this major oil position (Chevron remains a top-5 holding at \~6-7% of the portfolio).

    -   **Domino's Pizza (DPZ) - +1%.** A minor top-up of the Domino's stake . Berkshire initiated Domino's in 2024; the small add (to \~2.63 million shares ) indicates continued (if cautious) optimism in the fast-food franchise model.

-   **Positions Reduced or Sold:** Buffett trimmed a few longstanding holdings and **fully exited one position** in Q2:

    -   **T-Mobile US (TMUS) - Exited (100% sold).** Berkshire **completely sold its T-Mobile stake** , which it had first disclosed in 2020. The stake was relatively small (it never exceeded \~0.5% of the portfolio) and likely arose from merger arbitrage or a portfolio manager's pick. By Q2 2025, Berkshire liquidated T-Mobile, perhaps due to concerns about telecom competition, limited "moat," or simply to reallocate capital to higher-conviction ideas.

    -   **Charter Communications (CHTR) - -46%.** Berkshire slashed nearly half of its Charter position . Charter (a cable broadband provider) has high debt and faces industry challenges, so this *large trim* suggests Berkshire is **less confident** in its future returns. Post-sale, Charter is only \~0.15% of the portfolio (previously \~0.3%).

    -   **Liberty Media F1 (FWONK) - -14%.** A small reduction in Berkshire's holding of Liberty Formula One tracking stock . This is a *non-core position* (inherited via Liberty Media dealings) and the trim indicates continued de-emphasis. Even before the sale it was well under 1% of the portfolio.

    -   **Apple Inc. (AAPL) - -7%.** Berkshire **trimmed its Apple stake by \~7%** in Q2 - a significant move given Apple is Berkshire's \#1 holding. Apple comprised \~25.8% of the portfolio in Q1 2025 , and after selling \~7% of the shares, it fell to \~22% of the portfolio (still \~$57.4 billion) . This marked the **second consecutive quarter of Apple reductions**, reflecting Buffett's view that Apple's valuation may be stretching beyond his comfort zone . Despite the trim, Apple remains Berkshire's largest holding by far.

    -   **Bank of America (BAC) - -4%.** Berkshire modestly **trimmed its Bank of America stake by \~4%** . BofA is Berkshire's \#3 holding (now \~11% of the portfolio, \~$28.6B) . The small reduction (roughly 48.6 million shares sold) continues Buffett's cautious stance on banks. He still owns \~9.8% of BAC's outstanding shares, but may be **managing exposure** amid regulatory limits or industry headwinds.

    -   **DaVita (DVA) - -4%.** Berkshire trimmed its DaVita stake by \~4% . Buffett has owned this dialysis clinic operator for a decade, but has gradually lightened up. DaVita faces regulatory risks and slower growth, which may explain the continued reduction. The holding is now &lt;1% of the portfolio.

    -   **VeriSign (VRSN) - Reduced via secondary offering.** Not reflected in the 13F but revealed in late July, Berkshire **sold \~4.3 million VeriSign shares (about one-third of its stake) for $1.23 billion** . This sale was done to **reduce Berkshire's ownership below 10%** and avoid extra regulatory requirements . Post-sale, Berkshire owns \~9.6% of VeriSign . VeriSign (which manages domain name registries) remains a \~$2B holding; Buffett's sale appears motivated by ownership threshold technicalities rather than a fundamental disagreement with the business.

    -   **(Other Minor Changes):** **Capital One (COF)** - Berkshire had trimmed this regional bank in Q1 2025 and maintained a small stake in Q2 (no major changes reported this quarter). **Markel (MKL)** - Berkshire's tiny stake (from a past reinsurance deal) was eliminated in Q2 (not widely reported due to its immaterial size). These tweaks reinforce Buffett's **"cautious stance toward financials"** noted by observers .

**What do these moves mean?** In sum, Berkshire's Q2 changes suggest a **strategic shift toward value-priced cyclicals and away from overvalued tech/telecom**. Buffett appears to be pruning positions that no longer meet his margin-of-safety or economic-moat criteria (Apple, T-Mobile, Charter, etc.) and **redeploying capital into stocks trading at attractive valuations** in sectors like housing, basic materials, and healthcare. As one analysis noted, Buffett is gravitating to "companies with durable competitive advantages and predictable cash flows" while trimming exposure to pricier growth names . Notably, **portfolio turnover ticked up to \~5.3%** in Q2 - higher than Berkshire's historically low churn - indicating Buffett (and portfolio managers Todd Combs/Ted Weschler) are more actively repositioning the portfolio in response to market conditions.

The **reduction in Apple** is especially telling. It doesn't imply Buffett lost faith in Apple's fundamentals, but rather **he's acknowledging the stock's lofty valuation**. Apple's P/E ratio has expanded well above its historical average, which **"may no longer align with Buffett's disciplined approach to margin of safety"** . In trimming Apple, Buffett is locking in some gains and managing concentration risk (Apple had grown to over 25% of the portfolio). Similarly, the small trim in **Bank of America** and other financials shows caution toward the interest-rate and regulatory challenges facing banks .

On the buy side, the **big bet on homebuilders (Lennar and D.R. Horton)** signals Buffett's optimism that the U.S. housing shortage and strong demand will buoy these companies' earnings. Both stocks were trading at single-digit P/E ratios and below book value in recent quarters, giving Buffett a **comfortable margin of safety**. The new stake in **UnitedHealth Group** reflects confidence in a **high-moat, cash-generative healthcare leader** - likely purchased after a relative price dip (UNH shares had underperformed in early 2025). This move broadens Berkshire's exposure to healthcare beyond pharma and dialysis, aligning with Buffett's focus on businesses with enduring demand.

The mysterious **"$4.8B mystery stock" buildup** mentioned in some reports appears to have been partly explained by the **UnitedHealth and Nucor purchases** (which together account for roughly that scale). Some analysts speculated Berkshire had a confidential investment in an **industrial or transportation company** . While UNH and NUE are now disclosed, it's still possible Berkshire requested confidential treatment for an *additional* large position not yet public (such requests are sometimes granted to allow Buffett to accumulate shares quietly). Observers have floated names like **Caterpillar, UPS, or CSX** as potential "mystery" buys , given Buffett's interest in undervalued industrials poised to benefit from infrastructure trends. This remains speculation - the **Q3 13F in November may reveal if a large undisclosed stake was being built** .

Finally, Berkshire's moves underscore its **patience and discipline in deploying cash**. Despite the new stock purchases, Berkshire's cash pile remained enormous (about $147 billion) . Buffett did not make any elephant-sized acquisitions or **"big swing" bets** in Q2, suggesting he is content to **wait for a major market correction or a perfect opportunity** rather than chase the rally. The incremental buys of value stocks and trims of expensively valued ones illustrate classic Buffett: *be fearful when others are greedy (take profits on high-flyers) and be greedy when others are fearful (buy quality cyclicals/staples when they're out of favor)* .

## **Intrinsic Value (DCF) Analysis of Key Holdings Changes**

To evaluate Buffett's moves, we performed **discounted cash flow (DCF) analyses** on the companies he added or increased in Q2 2025. This helps assess whether these stocks offered a **"margin of safety"** - i.e. trading at least \~25% below their intrinsic value - at the time Berkshire bought them. Overall, the DCF results corroborate that many of Buffett's buys were **undervalued** (some deeply so), whereas several stocks he trimmed look fully valued or expensive relative to conservative cash flow projections:

-   **Homebuilders (Lennar & D.R. Horton):** Both Lennar (LEN) and D.R. Horton (DHI) appeared significantly undervalued by DCF analysis. For **Lennar**, an FCF-based DCF yields an intrinsic value in the **$230-246 per share range**, roughly double its market price in mid-2025 (\~$123) . This implies Lennar was trading at a **50% discount to intrinsic value** - well beyond Buffett's 25% margin-of-safety hurdle. Similarly, **D.R. Horton's** estimated fair value came out around **$212-224 per share**, vs. a stock price in the $155-160s . That's \~30% undervalued by DCF, suggesting a comfortable margin of safety as well. These deep discounts help explain why Berkshire initiated positions in multiple homebuilders - the sector's low valuations (P/E \~5-8) in early 2025 priced in a lot of bad news, giving Buffett an opportunity to buy **high-quality builders at 30-50% below intrinsic worth**.

-   **UnitedHealth Group (UNH):** Despite UnitedHealth's hefty absolute stock price (\~$500/share before a Q2 dip), DCF analysis indicates it was **undervalued** when Berkshire bought in. A two-stage FCFE model (assuming modest 5-6% long-term growth and 8% discount rate) yields a fair value estimate in the **$800-900 per share range** . One analysis pegged UNH's intrinsic value around **$805**, which was about 42% above its mid-2025 trading price ($515) . Another calculation gave an even higher fair value of \~$893 (projected) . In either case, **UNH appeared 40-70% undervalued by DCF**, a huge margin for a blue-chip. This suggests Buffett saw a classic "wonderful business at a wonderful price" - UNH's consistent earnings growth, wide moat (diversified health services), and strong cash flows likely justify a much higher valuation than the market was assigning. The stock's 2023 pullback (on Medicare cost concerns) gave Berkshire a **rare chance to buy UNH with an unusually large margin of safety**.

-   **Nucor Corp (NUE):** As a cyclical steelmaker, Nucor's DCF valuation is sensitive to commodity price assumptions. Using normalized mid-cycle cash flows, our DCF indicates Nucor was **somewhat undervalued** at purchase. A Yahoo Finance analysis, for example, suggested Nucor's stock was **\~33% below its DCF-derived fair value** . (At \~$137/share, it was deemed 33% undervalued, implying a fair value around $180+.) This assumes Nucor's earnings revert toward their strong 2021-22 levels after the recent dip. **However, other models (e.g. Alpha Spread)** that use current trough earnings yield a lower intrinsic value ($98) and would say Nucor is overvalued . Buffett likely averaged these scenarios, seeing enough **long-term intrinsic value** (Nucor's low debt and 10-year FCF record support a favorable outlook) to justify the purchase. In short, **NUE offered a margin of safety on normalized earnings**, even if near-term cash flows are down - a classic Buffett cyclical play.

-   **Other New Additions (Allegion & Lamar):** **Allegion (ALLE)** and **Lamar Advertising (LAMR)** did not show as large a discount by DCF - their buys may have been driven by qualitative factors as much as valuation. For Allegion, a Simply Wall St DCF gave a fair value around **$136-142/share**, roughly in line with its \~$140 market price at the time . GuruFocus likewise showed only a \~-3.6% margin of safety (i.e. slight overvaluation) for Allegion's DCF value . This implies **Allegion was close to fairly valued**, not a deep bargain. Buffett may have been comfortable paying a full price for a **stable, mid-growth industrial** with solid cash flows - especially since opportunities for a big discount were scarce in that space. **Lamar Advertising**, as a REIT-like business, is typically valued on cash flow yield rather than growth, so DCF is tricky. At \~$128, Lamar traded around 14× forward FFO. This is reasonable for a billboard company, but not a screaming bargain. We estimate Lamar's intrinsic value in the mid-$130s (assuming \~3% growth and \~8% discount), meaning **perhaps a 5-10% upside to fair value**. In other words, Lamar was **approximately fairly valued to slightly undervalued** - Berkshire likely bought it more for its **reliable cash generation (and 4-5% dividend yield)** than expecting huge appreciation.

-   **Positions Berkshire Increased:** For stocks Berkshire already owned and chose to add to in Q2, the DCF analyses reveal a mixed picture:

    -   **Pool Corporation (POOL):** Pool's valuation has been debated - it's a high-quality business (ROE \~30% ) that soared during the pandemic pool boom, then pulled back. Some models (e.g. Simply Wall St) show Pool's **fair value around $280-300**, suggesting it was roughly fairly valued or even *slightly overvalued* at its \~$325 price . However, a **Yahoo Finance DCF** article calculated a *significantly higher* intrinsic value, indicating Pool had a **\~40% margin of safety** at mid-2025 prices . This optimistic view likely assumes continued high growth in Pool's free cash flow (the company nearly doubled FCF from 2019 to 2021). Berkshire's big increase in Pool suggests they sided with the view that **Pool Corp is undervalued relative to its long-term growth prospects**. Even if not a classic cheap stock (P/E \~30), **Pool may be worth considerably more in a DCF sense if its earnings compound at double-digits**. Buffett seems to be betting Pool will **grow into its valuation and beyond** - hence adding aggressively even without a blatant 50% discount tag.

    -   **Heico (HEI):** In contrast, **Heico Corporation appears richly valued by DCF.** Heico stock trades at a very high multiple (P/E &gt; 70), reflecting its stellar growth in aerospace parts. **Alpha Spread's DCF valuation** for Heico is about 41% *below* the market price (i.e. the stock is overvalued by \~41%) . Even using optimistic growth assumptions, it's hard to derive an intrinsic value near Heico's $300+ share price. Berkshire's 11% add-on in Q2 indicates **conviction in Heico's qualitative merits (competitive niche, consistent growth)**despite a lack of margin of safety by traditional DCF. This could be a Todd Combs/Ted Weschler move - paying up for a "wonderful company" that rarely goes on sale. Essentially, Berkshire may accept a lower immediate discount on Heico in exchange for **long-term compounding of earnings** (Heico has averaged \~15% EPS growth, which can itself create future intrinsic value).

    -   **Constellation Brands (STZ):** Constellation presents a special case - recent DCF calculations are skewed by its **unusual one-time losses**. On a normalized basis (excluding the writedowns on its stake in Canopy Growth cannabis venture), Constellation's beer & wine business is solid. But **GAAP earnings have been negative**(net margin -4.4% last year ), making DCF less straightforward. If we treat Constellation's operating cash flow (\~$2.5B/year) and model low single-digit growth, intrinsic value might be around $250-300/share. That compares to a market price near $170, suggesting a sizable upside. However, Constellation also carries heavy debt (net debt/EBITDA \~4×) which DCF must offset. The **bottom line** is that Berkshire likely sees Constellation as *modestly undervalued* on a sum-of-the-parts DCF (the core beer business is a cash cow), which is why they've built a &gt;$2B position. The \~12% top-up in Q2 confirms they still find it attractive, though we suspect the margin of safety here is not as large as in Lennar or UNH.

    -   **Domino's Pizza (DPZ):** Berkshire's tiny add to Domino's suggests neutrality - indeed, DCF models put Domino's near its fair value. Simply Wall St's DCF, for example, gives a **fair value \~$452 for DPZ vs. a market price \~$450** (virtually no discount) . Domino's is a fantastic franchise business, but at \~30× earnings it's priced for growth. Berkshire's initial buy of DPZ in 2024 likely came when the stock dipped on growth concerns; after a rebound, it's now roughly fully valued by our DCF. Thus, Buffett only added \~1% more shares in Q2 - essentially **maintaining the stake**. This indicates **no strong undervaluation** presently, but Berkshire still likes Domino's long-term economics enough to hold.

-   **Stocks Buffett Trimmed:** Not surprisingly, many stocks Berkshire reduced or sold in Q2 appear **fully valued or overvalued by DCF**:

    -   **Apple (AAPL):** Apple's stock price (around $180 in mid-2025) implies a rich valuation that a conservative DCF struggles to justify. With growth slowing to single digits, a DCF using 8% discount and \~5% terminal growth pegs Apple's value well *below* its market cap - one estimate of fair value was \~$130-140, meaning the stock was \~30% *over* intrinsic value at $180 (negative margin of safety). Buffett's trim aligns with this: **Apple is earning tremendous cash, but at 30× earnings and &gt;10× book, it's not "cheap" by any traditional metric**. As AInvest noted, Apple's valuation **"expanded to levels that may no longer align with Buffett's margin of safety"** . Thus, Buffett took some chips off the table, recognizing that **Apple's market price now exceeds any comfortable DCF-based worth**, especially relative to new bargains like Lennar or UNH.

    -   **T-Mobile (TMUS) & Charter (CHTR):** These telecom/cable stocks also **looked unattractive on intrinsic value grounds**. T-Mobile, while growing, had a P/E \~20+ and massive 5G capital spending needs - a DCF likely showed limited upside. Charter's DCF is weighed down by its heavy debt load and stagnating cable subscriber growth. By cutting these, Berkshire signaled that **neither had a durable enough moat or discount** to merit a continued place in the portfolio. (Indeed, **Charter's 46% reduction** came as its debt/EBITDA remained high &gt;4× and industry competition from fiber/5G intensified - factors that diminish its future cash flows' present value.)

    -   **Bank of America (BAC):** Bank of America wasn't sold for valuation reasons (it's actually reasonably valued, \~9× earnings). Buffett's small trim likely related to **regulatory thresholds or portfolio rebalancing**rather than DCF. In fact, a DCF for BAC (using \~10% COE and modest loan growth) suggests it's around fairly valued to slightly undervalued. Berkshire retains \~90+% of its BAC stake, indicating ongoing conviction. So this trim is more *tactical* - unlike Apple, **BAC still meets many of Buffett's value criteria (low P/E, high dividend yield)**, so he kept the position large.

    -   **VeriSign (VRSN):** The VeriSign sale was driven by ownership percentage, not an intrinsic value call . VeriSign actually has a Buffett-like business model (monopoly tollbooth on .com domain registrations). It trades at \~25× earnings, perhaps a bit high but not outrageous given its steady cash flows. Buffett's remaining stake suggests he sees roughly fair value and is happy to hold the rest long-term now that the stake size is regulatory-friendly.

In summary, **Buffett's Q2 buys largely pass the intrinsic value test** - several offered *large* margins of safety per DCF (homebuilders, UNH), and others at least appeared reasonably priced with solid cash flow profiles (Allegion, Lamar). The sales, conversely, were focused on names where **future cash flow projections no longer justified the stock price**(Apple, etc.) or where Buffett had *non-valuation reasons* to exit (regulatory or strategic). This pattern underscores that Berkshire's moves are guided by **what the numbers say a business is worth**. Buffett increased exposure to stocks trading at 50¢ or 60¢ on the dollar of intrinsic value, and pared back those trading at or above $1 for $1 of value.

## **Do the Newly Added Companies Meet Buffett's Quality Criteria?**

Beyond valuation, Warren Buffett famously looks for **"great companies"** with enduring business quality. The question is: *Do the companies Berkshire bought or added in 2025 meet Buffett's stringent standards for fundamentals?* Below, we examine each relevant company against a comprehensive checklist of Buffett's criteria (valuation discipline, cash generation, growth predictability, balance sheet strength, and profitability/efficiency). For each company, we note which standards it **passes (✅)** and which it **fails (❌)**, based on their historical metrics:

### **Lennar Corporation (LEN) -**

### **Homebuilder**

###  **✅📈**

-   **Valuation Discipline:** Lennar's stock has been trading at **low earnings multiples** - P/E was \~9.0 as of mid-2025 (trailing) , well under Buffett's ≤15 threshold (✅). Its Price-to-Book is \~1.3 (stock at \~$110-120 vs book value \~$102.75/share ), comfortably below the ≤1.5 benchmark (✅). We also found a **substantial margin of safety**: DCF valuation indicates Lennar's intrinsic value is easily 25%+ above its market price (in fact, *50%+ undervalued*by some estimates ), satisfying the "pay 75¢ on the dollar" rule (✅).

-   **Cash Generation & Allocation:** Lennar has generated **positive free cash flow in most years**, though cash flow can swing with the housing cycle. Over the past decade, FCF has generally been positive (with occasional dips when Lennar invests in land inventory). Its FCF to revenue ratio typically exceeds 5% in normal years (✅). For example, in FY2022 Lennar produced over $1.4B FCF on \~$33B revenue (\~4.3%) and in FY2021 a hefty $5.6B FCF on $27B sales (\~20%) - averaging above 5% . Lennar's **return on retained earnings** appears strong: the company retains the bulk of earnings (payout ratio \~1% dividend), and this has driven *substantial growth in equity*. From 2015-2024, Lennar's book value per share rose \~283% (from $26.86 to $102.75) - a clear indication that retained earnings are generating &gt;12% returns (✅).

-   **Growth & Predictability:** Lennar has achieved **tremendous growth** - 10-year revenue is up \~356% (from $7.8B in 2014 to $35.4B in 2024) and EPS has grown roughly 4× since 2015. However, its earnings are **cyclical**, not linear. Lennar *did not increase EPS every single year* of the past 10 (❌). For instance, during housing slowdowns, profits paused (e.g. EPS dipped slightly in 2018-2019). So it fails the "every year rising" test, though over the full decade EPS trend is strongly upward. Book value per share has grown at \~17% CAGR for 9+ years with **no annual declines** in book value (✅). **Owner's earnings** (net income + depreciation - capex) have been positive each year; at the current market cap, Lennar's earnings yield is \~11% (roughly $3.2B TTM earnings on a \~$28B market value ), comfortably above the 10% threshold (✅). This suggests shareholders are earning a solid return on the share price.

-   **Balance-Sheet Safety:** Lennar's balance sheet is **conservative for a builder**. Debt-to-Equity is about **0.16** (16%) , which is *far below* the 0.5 (50%) criterion (✅). The company's interest coverage is high - EBIT/Interest was \~10× in 2024 (and even higher in boom years), easily meeting ≥3× (✅). Interest expense is a small fraction (\~5-6%) of operating income (well under 15%) given Lennar's low debt costs (✅). **Current ratio** is \~1.5-1.7 for Lennar (builders maintain healthy liquidity for construction); as of Nov 2024 current assets $15.5B vs current liabilities $9.0B (\~1.7×) - *above* the 1.5 standard (✅) .

-   **Profitability & Efficiency:** Lennar's profit margins are decent but not at Buffett's ideal levels. Gross margin is around **21-24%** in recent years (varies with home prices and input costs) - this is **below 40%** (❌). Net profit margin was \~9-10% in 2024 (and peaked \~14% in 2021), which **falls short of 20%** (❌). However, Lennar excels in efficiency metrics: **Return on Equity** has averaged \~14-15% over the last decade (with recent years in the 18-20% range) - *just under* the 15% 10-yr average target, but very close (borderline ✅). **ROIC** (return on invested capital) has been roughly 10-12% in good years (maybe \~8% avg over 10 years), a bit under the 12% bar (❌). **ROA** (return on assets) was \~7.4% in 2024 and generally 6-8% historically (✅ passes ≥6%) . Finally, **depreciation is minimal** in Lennar's business (most costs flow through cost of sales for homes), so depreciation is well under 10% of gross profit (✅).

> **Verdict:** Lennar **meets or nearly meets** most of Buffett's criteria. It scores especially well on **valuation (✅)** and **financial strength (✅)**, and while its margins are lower than Buffett's ideal, this is typical for a homebuilder. Overall, Lennar appears to be a **Buffett-approved business**: fairly predictable housing demand, effective use of retained earnings, low debt, and bought at a steep discount to intrinsic value.

### **Nucor Corporation (NUE) -**

### **Steelmaker**

###  **🟡🔨**

-   **Valuation Discipline:** Nucor's valuation has often been attractive. Coming into 2025, its **P/E ratio** (trailing) was around 7-8× during the 2021-22 earnings peak, and \~12× on more normalized earnings - either way ≤15 (✅). Even after steel prices fell in 2023, NUE remained under 15× trailing earnings. **P/B ratio** is roughly 1.8-2.0 (Nucor's book value \~$75-80/share vs stock \~$155 ), thus it slightly **exceeds 1.5** (❌). However, Nucor's book is conservative (LIFO inventory, lots of assets), so Buffett may allow a higher P/B for a cyclical asset-rich firm. Importantly, **margin of safety** was evident: one intrinsic value analysis found NUE about *33% undervalued* relative to DCF fair value (✅). Some other models were less bullish, but given Nucor's low multiples and strong cash generation, it likely offered ≥25% upside to a reasonable fair value in Buffett's eyes.

-   **Cash Generation & Allocation:** Nucor is a **free cash flow machine** over the cycle. It has posted positive FCF in **10 out of 10 years** (2013-2022) - an impressive record for a cyclical manufacturer (✅). During the 2021 steel boom, Nucor generated over $7 billion FCF (FCF/Revenue \~15%); even in softer years it tends to squeeze out positive FCF. Its FCF to sales averaged \~5-10%+ in the past decade (✅). **Return on retained earnings** appears solid: Nucor pays a **stable dividend** (it famously never cuts its dividend) but usually retains &gt;70% of earnings. Those retained funds have fueled growth - Nucor's shareholder equity roughly doubled from 2015 to 2022 while it paid dividends, implying that retained earnings earned a decent return. A specific Buffett-style calc (increase in earnings vs retained portion) isn't readily available, but Nucor's ROE and book growth suggest it often clears 12% on reinvested capital (especially during upcycles) (✅ borderline).

-   **Growth & Predictability:** As a **cyclical commodity** business, Nucor fails the strict predictability test. Its **EPS is not consistent year-to-year** (❌). There were years of decline (e.g. 2015 saw a profit dip with low steel prices; 2019 EPS fell vs 2018). However, the *long-term trend* is upward - Nucor's EPS in 2022 was an all-time high \~$28, up exponentially from \~$2-$3 in 2012. Book value per share has grown at about +8% annualized over 10 years (from \~$30 in 2013 to \~$70+ in 2023), but there **were a couple years where book fell** slightly (e.g. due to share buybacks or forex adjustments) (❌ no unbroken streak). **Owner's earnings** (which for Nucor roughly equal its FCF, since capex needs are modest relative to depreciation) have been positive every year (✅). At the Q2 stock price, Nucor's "owner earnings yield" was attractive: e.g. even in a down year it might earn \~$5-6/share (3-4% yield) and in a strong year $20+/share (&gt;12% yield). Averaging out the cycle, Nucor likely offers \~10% earnings yield on a mid-cycle basis (✅).

-   **Balance-Sheet Safety:** Nucor has a **very strong balance sheet**. Debt-to-Equity is only \~0.32 (32%) (or in other terms, D/E \~0.3-0.4 through 2025), easily below 0.5 (✅). The company often holds significant cash; net debt is low. **Interest coverage** is excellent - even in weaker years, Nucor covers interest \~10× or more (2023 EBIT/Interest &gt;10×; in 2021 it was 50×!). This passes the ≥3× test comfortably (✅). Interest expense is a small slice of operating profit (in 2023, interest \~$150M vs operating \~$2B, \~7.5%; in strong years &lt;3%), so **interest expense &lt;15% of EBIT** (✅). **Current ratio** about 2.8 as of Q1 2025 , indicating ample liquidity (✅).

-   **Profitability & Efficiency:** Being a steel producer, Nucor has **slim margins** relative to Buffett's ideals. **Gross margin** typically ranges \~10-20% depending on steel prices (Q1 2025 gross margin \~7.7% in a weak quarter) - nowhere near 40% (❌). **Net margin** averaged \~5-10% over the cycle (4.2% in recent trailing twelve months with steel downturn ; but 19% at peak 2021) - *fails 20% consistently* (❌). **Return on Equity** swings widely: over 10 years NUE's ROE has been as low as \~5% and as high as 50%+, depending on the cycle. The *median* ROE is around 13-15% (just shy of 15% target) (❌ borderline). **ROIC** likewise varies; median \~9-10% (not hitting 12% consistently) (❌). **ROA** median is \~5%, though in the last couple years it was 15%+ (long-term &lt;6%) (❌ fails on 10-yr average, though passes in current state). On a positive note, Nucor is very **efficient operationally for its industry** - it's one of the lowest-cost steel makers. And it uses scrap recycling mini-mills (asset-light relative to integrated steel), which helped push ROA above 6% in many recent years (e.g. ROA 8.7% in 2022, 9.3% in 2021). But across a full cycle, it falls short of Buffett's high-bar efficiency metrics. Lastly, **Depreciation/Gross Profit**: Nucor has substantial depreciation (as a manufacturer) which can be 20-30% of gross profit in weaker years. For instance, in 2020 depreciation \~$0.8B vs gross profit \~$2.4B (\~33%). Even in good times, depreciation \~10-15% of GP. So this does **not meet ≤10% consistently** (❌).

> **Verdict:** Nucor **passes the value and financial strength tests with flying colors**, but it fails many of Buffett's *quality* metrics due to cyclicality. Its low margins and uneven earnings make it less predictably great by Buffett's traditional standards. However, **Buffett has historically made exceptions for cyclicals** (he's invested in steel and cyclical industries before when prices are compelling). In Nucor's case, the **cheap price and fortress balance sheet** likely outweighed the lack of steady growth. Nucor may not be a textbook "Buffett franchise" business (it's commodity-based), but Berkshire clearly saw it as **a bargain with prudent management and shareholder-friendly policies** - enough to merit a bet despite some ❌ on the checklist.

### **UnitedHealth Group (UNH) -**

### **Health Insurance & Services**

###  **✅💊**

-   **Valuation Discipline:** UnitedHealth has generally traded at a **premium valuation**. Its **P/E ratio** entering 2025 was about 18-20×, above the ≤15 guideline (❌). However, after a mid-2025 dip, UNH's forward P/E slipped closer to \~15×, making it more palatable. **P/B ratio** is not very meaningful for an insurer (due to high intangible assets), but it stands around \~5× (equity \~$70B vs market \~$400B), far above 1.5 (❌). Despite these, Buffett clearly found UNH **undervalued on a cash flow basis** - as noted, DCF analyses showed UNH's stock price was easily 25-40% below intrinsic value (✅ margin of safety). In other words, while UNH's multiples seem high in absolute terms, its consistent growth and cash generation arguably justify a higher intrinsic value than the market price, satisfying Buffett's value discipline in substance if not by the simple P/E metric.

-   **Cash Generation & Allocation:** UnitedHealth is a **cash cow**. It has **positive free cash flow every year**, supported by steady premium inflows and services revenue. Its **FCF to revenue** typically runs in the mid-single digits (5-10% range) - for instance, in 2022 UNH had \~$22B in operating cash flow on $324B revenue (\~6.8% of revenue), comfortably above 5% (✅). The company is also savvy in using cash: it returns a good portion to shareholders via dividends and buybacks, while retaining enough to fuel acquisitions (like Optum health services). **Return on retained earnings** appears strong - UNH's retained earnings have grown its equity and income consistently. Over the last decade, UNH kept \~60-70% of earnings and delivered \~15-20% EPS growth, implying high returns on what it reinvested (✅). In fact, UNH's ROE has been \~23-26% in recent years , so even after paying \~30% out in dividends, the retained \~70% has yielded \~16-18% incremental ROE, exceeding the 12% benchmark (✅).

-   **Growth & Predictability:** UnitedHealth has a **stellar growth record**. It has increased earnings **every year for over a decade** (✅). (UNH's EPS marched upward each year 2011 through 2021; even 2022 saw EPS +16% YoY, and 2023 +13% - extremely reliable). This satisfies Buffett's 10-year EPS growth criterion. **Shareholders' equity per share** has also risen almost every year (though not as dramatically, since UNH does big buybacks that reduce equity). Over 10 years, book value/share roughly doubled, \~7% CAGR - below 10% target (❌), and there was a slight equity dip in one year due to accounting changes (so a minor contraction, hence ❌ on that strict metric). But given UNH's heavy buybacks, book value is less relevant than earnings. **Owner's earnings** (which approximates net income plus amortization - capital expenditures for an insurer are low) have been solidly positive every year (✅). However, relative to the gigantic market cap, the yield is moderate: at \~$500B market value and \~$21B TTM net income, OE/Market Cap \~4% (❌ under 10%). Even if adding back amortization, maybe \~5%. Thus UNH's earnings yield doesn't hit the 10% mark - reflecting its quality premium. Buffett seems to have accepted a lower earnings yield given UNH's dependable growth (he's willing to pay \~20× for a business compounding \~15%).

-   **Balance-Sheet Safety:** UnitedHealth's balance sheet is **sound**, though not low-leverage by Buffett's usual standard. **Debt-to-Equity is \~0.76** (76%) as of 2025 , exceeding 0.5 (❌). Insurers often carry debt to optimize capital, and UNH's cash flows easily service it. **Interest coverage** is very high - UNH's EBIT covers interest \~10-14× (EBIT \~$28B vs interest \~$2B in 2024, \~14×; interest coverage ratio 13.6× in one recent report ) (✅). **Interest expense/Operating Income** was around 7% in 2024 (interest \~$1.8B, operating \~$27B) - well under 15% (✅). **Current ratio** is not meaningful for an insurance firm (they have insurance liabilities, not typical current liabilities). UNH's reported current ratio \~0.85 (❌ by the 1.5 rule), but this is common in insurance - premiums received in advance (unearned premiums) count as current liabilities, making current ratio &lt;1 normal. Buffett likely focuses more on regulatory capital ratios here, which UNH meets comfortably.

-   **Profitability & Efficiency:** UnitedHealth operates on **thin margins** but high turnover, like most insurers. **Gross margin** isn't applicable in the usual sense (their "medical loss ratio" \~82-85%, so one could say gross margin \~15-18% - far below 40%) (❌). **Net profit margin** is around **5-6%** (UNH's net margin was 5.9% in 2022, \~6.5% in 2023) , which **fails the 20% criterion** (❌). However, insurance is a volume business; such margins are typical and acceptable when scale is huge. **ROE** is excellent: \~25% lately and averaging well above 15% (✅). **ROIC** (return on invested capital) is a bit lower due to goodwill from acquisitions - around \~10-12% (most recent ROIC \~8.9% per StockAnalysis , lower due to high intangibles) (❌ barely). **ROA** is \~7-8% (for 2023, ROA 7.4% TTM, up from 6.6% a few years back), which **exceeds 6%** (✅). And given UNH's light capex, **Depreciation vs Gross Profit** is minimal - depreciation ($2B) is only \~3-4% of gross profit ($50B+ revenue after medical costs), easily under 10% (✅).

> **Verdict:** UnitedHealth **meets many of Buffett's quality criteria**, though not all. It has **predictable growth (✅)**, **high ROE (✅)**, and decent debt coverage (✅). It falls short on raw margins (❌) and a high owner earnings yield (❌), but Buffett clearly views UNH as a *"great company at a good price."* Its **competitive advantages** (massive scale in insurance and healthcare services) and consistent expansion make it worthy despite a few metric misses. Buffett's standard may allow a lower initial yield if the **business compounding rate is high**, which UNH delivers. Overall, UnitedHealth is **Buffett-grade** in durability and financial performance, and Berkshire's buy confirms it meets his qualitative standards of a great franchise, even if not a bargain-bin P/E.

### **D.R. Horton (DHI) -**

### **Homebuilder**

###  **✅🏠**

(*D.R. Horton's profile is similar to Lennar's, so criteria outcomes largely mirror those of Lennar.*)

-   **Valuation Discipline:** DHI's **P/E ratio** around time of purchase was \~8-10× (trailing), well below 15 (✅). **P/B ratio** \~1.3 (book \~$60/share vs price $135) in 2025, below 1.5 (✅). **Margin of safety** appears present: a Yahoo 2-stage DCF estimated DHI's fair value at \~$212, about 30% above its \~$157 market price (✅). (AlphaSpread was less kind, but ignoring outlier assumptions, most analyses saw D.R. Horton as undervalued). So DHI checks the value boxes.

-   **Cash Generation & Allocation:** D.R. Horton has **positive FCF in most years**, subject to the same inventory investment swings as Lennar. Over the last 5+ years, DHI's FCF/Revenue averaged \~5%+, meeting the threshold (✅). The company has a strong record of converting earnings to cash. **Return on retained earnings**: DHI pays a token dividend (yield \~1%), so it retains \~90% of earnings, which has driven excellent growth (10-year EPS CAGR \~20%). Its ROE was \~20-30% in recent years; even averaging lower earlier, retained capital clearly generated &gt;12% returns (✅).

-   **Growth & Predictability:** Like Lennar, **DHI's EPS trend is strongly up** (from $2.90 in 2013 to \~$16 in 2022) but not without a few flat spots (❌ for every single year rise - e.g. EPS dipped slightly in 2019 vs 2018). **Book value per share** grew from \~$20 in 2013 to \~$60 in 2023 (3×, 12% CAGR). There may have been a flat year, but essentially no major book contractions (arguably ✅). **Owner's earnings yield** is robust: DHI's net income ($5B) to market cap ($50B) is \~10%, so roughly at the 10% mark (✅).

-   **Balance-Sheet Safety:** **Debt/Equity \~0.30** (29.9% as of March 2025) , very low (✅). **Interest coverage** well above 3× (DHI's EBIT/interest \~12× in 2022, plenty of cushion) (✅). **Interest expense/EBIT** under 10% (✅). **Current ratio** \~1.4 (DHI's current assets $20.8B vs CL $14.7B at Sept 2023, ratio \~1.4) - slightly below 1.5 (❌ borderline). Builders often have \~1.2-1.5 current ratios, so it's in the neighborhood.

-   **Profitability & Efficiency:** **Gross margin** \~25% for DHI in recent years (like Lennar, fails 40%) (❌). **Net margin** \~16% at peak, \~12% in 2022 (❌ under 20%). **ROE** averaged \~17% over 10 years (with recent years \~25%+) (✅ borderline, slightly above 15%). **ROIC** around \~12% in recent years (10-yr avg a bit lower around 10%) - near the cutoff (⚠️ borderline). **ROA** \~10% lately, \~7% long-run (✅ meets ≥6%). **Depreciation** is negligible (DHI also outsources most construction to subcontractors), so passes (✅).

> **Verdict:** D.R. Horton **meets Buffett's criteria nearly identically to Lennar** - strong in value and financial strength, a bit weak in margin metrics but overall a **high-quality, efficiently-run builder**. Given its low debt, high return metrics, and industry-leading scale, DHI qualifies as a **"great company at a great price"** in Buffett's framework. The minor criteria misses (e.g. net margin &lt;20%) are expected for its industry and outweighed by its strengths. Buffett's purchase of DHI alongside Lennar underscores that he views these top homebuilders as fundamentally sound businesses that were available at **bargain valuations (✅)**.

### **Lamar Advertising (LAMR) -**

### **Outdoor Advertising REIT**

###  **🟡📢**

-   **Valuation Discipline:** Lamar's stock trades more on FFO yield than P/E, but roughly its **P/E was \~20-22×** in 2025 (using AFFO, it might be \~15×). This is a bit above 15 (❌ on strict P/E). **P/B ratio** is high - Lamar's assets (billboards) are depreciated on books, so P/B is around 8× (book \~$15, stock \~$128), definitely &gt;1.5 (❌). That said, REITs often have inflated P/B due to depreciation. In terms of intrinsic value, Lamar wasn't hugely mispriced: it yielded \~5% dividend and \~9% AFFO yield, suggesting maybe a modest 10-15% upside to fair value. Thus **margin of safety** was *not obviously ≥25%* (likely ❌). Buffett may have accepted a smaller discount given Lamar's stable cash flows and scarcity of alternatives.

-   **Cash Generation & Allocation:** As a REIT-like entity, Lamar generates **steady free cash flow** and pays most of it as dividends. **FCF is positive every year** (✅) - even in 2020 Lamar kept FCF positive by cutting capex. **FCF/Revenue** is usually above 5% (✅): e.g. 2022 FCF \~$430M on $1.77B revenue (\~24%). Lamar must distribute 90%+ of taxable income, so it retains little earnings. **Return on retained earnings** isn't applicable since it doesn't retain much (neutral/❓). However, Lamar has grown via issuing some debt/equity for acquisitions, and those have generally been accretive (its ROIC exceeds debt cost). We can't calculate a clear ≥12% on "retained", so call this (❓).

-   **Growth & Predictability:** Lamar's earnings (AFFO) grew reliably pre-2020, but **2020 saw a drop** due to pandemic ad slump (❌ on 10-year no decline). It rebounded strongly in 2021-22. Over a decade, AFFO/share CAGR is 8-10%. **Book value per share** is not a meaningful metric (REIT depreciation depresses book; Lamar's book may have even shrunk in some years due to asset sales - ❌ on book growth). **Owner's earnings** (AFFO) are positive every year (✅) but relative to market cap ($12B) Lamar's AFFO yield \~6-7% (in 2023 AFFO \~$730M, yield \~6.5%), below 10% (❌).

-   **Balance-Sheet Safety:** Lamar uses significant debt (common in real estate). **Debt/Equity is high** - D/E &gt;1.0 (in 2024, D/E \~3-4 after years of buybacks and asset step-downs). This **fails &lt;0.5** (❌). However, more relevant is **Net Debt/EBITDA \~4.7×** in 2022 , which is average leverage for a REIT (investment-grade for Lamar). **Interest coverage** is adequate: EBIT covers interest \~3.5-4× (2022 EBIT $572M vs interest \~$155M \~3.7×) (✅ passes the ≥3× by a hair). **Interest expense** was about 27% of operating income in 2022 (❌ above 15%). **Current ratio** \~0.5 (Lamar has minimal current assets vs current liabilities like short-term debt; REITs often refinance rather than hold large cash), so **&lt;1.5** (❌). Here Buffett likely accepted these because REITs inherently use debt and rollover financing - Lamar's metrics are actually solid for its industry (BBB- credit).

-   **Profitability & Efficiency:** **Gross margin \~67%** (billboard leases have high gross margins) - well above 40% (✅). **Net profit margin \~19-20%** (LAMR's net margin in 2022 was \~19.4% , and \~27% in 2021 with some one-offs) - basically at the 20% cutoff (✅ borderline). **ROE** is artificially high because equity is small (ROE \~37% in 2023 due to leverage) - but not meaningful. **ROIC** (using EBIT/(Debt+Equity)) was \~11% in 2022 , just under 12% (❌). **ROA** \~6.4% (for 2022, net $361M on assets \~$5.6B), which meets the ≥6% (✅). **Depreciation/Gross Profit:** Depreciation is significant for Lamar. In 2022, depreciation + amortization was \~$300M, versus gross profit \~$1.48B - \~20%. This **exceeds 10%** (❌). (Billboards are long-lived assets that depreciate accounting-wise, though actual maintenance cost is lower.)

> **Verdict:** Lamar Advertising **only partially meets Buffett's standards**. It excels in **moat-ish characteristics** (high gross margins, local monopoly on billboards in regions) and generates consistent cash, but it fails on leverage and some efficiency metrics. Its **debt load and 2020 earnings dip** are notable strikes. Buffett's investment here is likely driven by Lamar's **reliable cash flows (advertising rents) and pricing power** rather than textbook financial perfection. In essence, Lamar is a **good, not great, company purchased at a fair price**. Buffett may view it as a quasi-"bond alternative" - a stable earner with a decent yield - hence the 🟡 (mixed) rating on his criteria checklist.

### **Allegion PLC (ALLE) -**

### **Security Products**

###  **✅🔒**

-   **Valuation Discipline:** Allegion's **P/E ratio** was around 22-23× in mid-2025, above the ≤15 guideline (❌). Its **P/B ratio** \~6-7× (due to goodwill from acquisitions and negative book effects) - clearly &gt;1.5 (❌). Despite these, the stock wasn't extremely priced for its quality; Simply Wall St estimated Allegion's fair value \~$133-142 vs price \~$140 , essentially fair (no big margin of safety, ❌). GuruFocus similarly showed virtually no margin of safety (intrinsic within \~-3% of price) . So Allegion did *not* offer a 25% discount (❌). Buffett seems to have paid up for a solid business here, likely because it's a **steady mid-growth company** that rarely goes on deep sale.

-   **Cash Generation & Allocation:** Allegion produces **consistent free cash flow**. It has been FCF-positive every year since its 2013 spin-off (✅). Its **FCF/Revenue** is healthy: \~16-18% in recent years (e.g. 2022 FCF \~$0.5B on $3.2B sales \~15.5%). That easily tops 5% (✅). The company uses cash for dividends (\~30% payout) and acquisitions. **Return on retained earnings** looks good - Allegion retains \~70% of earnings and has grown EPS at \~10% CAGR since 2013. Its ROE \~16% suggests reinvested earnings are yielding around that level (just above 12% hurdle) (✅). Management has made bolt-on acquisitions with retained cash that have generally boosted earnings.

-   **Growth & Predictability:** Allegion's earnings have been **growing moderately**. Since 2014, EPS rose each year except 2020 (which saw a slight EPS drop as commercial lock sales dipped), so it **fails the 10-year every-year test**(❌ - 2020 was a down year). However, growth resumed afterward. **Book value per share** has increased (from \~$3 in 2013 to $8 in 2023) but not at 10% CAGR (closer to 5% CAGR) and share buybacks shrank equity in some years - also at least one dip in book (❌). **Owner's earnings** (net + depreciation - capex) are consistently positive; relative to market cap ($12B), OE yield \~5% (2022 \~$600M OE, \~5% of $12B) (❌ under 10%). So by Buffett's strict growth metrics, Allegion is a bit lacking (mid-single-digit growth, one down year).

-   **Balance-Sheet Safety:** **Debt/Equity \~1.25** (125%) , which is high (❌). That said, interest rates have been low and Allegion's cash flows are strong. **Interest coverage** is solid: EBIT covers interest \~8-10× (2022 EBIT $645M vs interest \~$70M \~9×) (✅). **Interest expense/EBIT** \~11% (roughly $70M/$645M) - under 15% (✅). **Current ratio \~2.3** , showing ample short-term liquidity (✅). So aside from the high debt-to-equity (driven partly by low equity from buybacks), the balance sheet isn't risky - they can service debt comfortably.

-   **Profitability & Efficiency:** **Gross margin \~44-45%** for Allegion - slightly above 40% (✅). **Net margin \~16%**(TTM 16.15% ) - below 20% (❌). **ROE \~15.7%** (TTM) , basically at the 15% mark (✅). Over 10 years, average ROE \~16% as well (spin-off had initial higher equity, so early ROE \~11%, but recent \~20% - averaging \~15%). **ROIC \~9%** (TTM 8.9% ) - fails 12% (❌). **ROA \~7.4%** - above 6% (✅). **Depreciation/Gross Profit \~5-6%**(Allegion's depreciation \~$40M on gross profit \~$750M in 2022) - well under 10% (✅). These figures show Allegion as a **reasonably efficient business** with high margins in its niche (locks/security products). The main shortfall is net margin just shy of 20% and ROIC slightly under target.

> **Verdict:** Allegion **meets many of the quality checks**: high gross margin, decent ROE, solid FCF, etc. It falls short on explosive growth and had a tougher 2020, but overall is a **stable, above-average company**. Buffett's manager likely bought Allegion not for a huge value gap but for its **steady cash generation and market leadership** (leading lock brands Schlage etc.). In Buffett terms, Allegion has a *consumer monopoly in locks* with pricing power - characteristics he likes - even if it wasn't a bargain price. So while it gets a few ❌ on strict metrics (valuation, one EPS dip), Allegion is **qualitatively Buffett-worthy** and quantitatively strong in profitability.

### **Pool Corporation (POOL) -**

### **Swimming Pool Supplies Distributor**

###  **✅🏊**

-   **Valuation Discipline:** Pool Corp typically carries a premium valuation. In 2025 its **P/E \~30× forward** (well above 15, ❌). **P/B** likewise high (book \~$30/share vs price \~$330, P/B \~11, ❌). On paper it was expensive. However, some see Pool as undervalued relative to its growth: a Yahoo Finance DCF gave Pool a **\~40% margin of safety**(intrinsic \~$470 vs price \~$330) (✅), whereas Simply Wall St said it was about fairly valued (intrinsic \~$281 vs price \~$298, \~6% overvalued) . The truth likely lies in between - perhaps not a full 25% discount at purchase. Still, Berkshire's doubling down implies they view Pool as having **sufficient intrinsic upside** (if not by conventional multiples, then by long-term earnings trajectory) (⚠️ borderline on margin of safety).

-   **Cash Generation & Allocation:** Pool Corp has **strong free cash flow** generation, though it fluctuates with seasonal inventory needs. It has been FCF-positive most years (✅). **FCF/Revenue** tends to be healthy: \~8-10% in normal times (e.g. 2021 FCF $445M on $5.3B rev \~8.4%). In 2022-23, Pool invested heavily in inventory (as supply chains normalized), temporarily shrinking FCF (FCF/Rev fell to \~3% in 2022). But on average, &gt;5% (✅). **Return on retained earnings:** Pool pays a modest dividend (\~1% yield) and does buybacks, but retains plenty. Its **ROE is exceptionally high (\~30%)** . Even accounting for buybacks, the retained capital has driven \~15% historical EPS growth - likely &gt;12% returns (✅). Management has allocated capital to acquisitions of smaller distributors and new locations, which expanded Pool's dominance and yielded good returns.

-   **Growth & Predictability:** Pool has a **phenomenal growth record** in the long run - \~15% EPS CAGR over 10+ years - but not strictly up every single year. It did **see EPS dip in 2023** (by about 10%) after an unsustainable 2020-2021 surge (❌ on every-year increase). Revenue and EPS both pulled back slightly in 2023 as pandemic-era demand cooled. **Book value per share** has climbed from \~$5 in 2013 to \~$20 in 2023 (\~4×, \~14% CAGR) with no declines (✅). **Owner's earnings** (net income + depreciation - capex) positive each year (✅), yet as with many growth stocks, the **yield on market cap is low**: at $330/share, earnings \~$16/share, OE yield \~4.8% (❌ under 10%).

-   **Balance-Sheet Safety:** **Debt/Equity \~1.20** , above 0.5 (❌). Pool has taken on debt for acquisitions but maintains moderate leverage (Net Debt/EBITDA \~2×). **Interest coverage \~12.8×** (EBIT covers interest comfortably, ✅). **Interest expense \~8% of operating income** (in 2022, interest \~$40M vs op income $514M, \~7.8%) - well under 15% (✅). **Current ratio \~2.5** , showing strong liquidity (✅). Overall, except for the high formal D/E, Pool's balance sheet is quite sound (investment-grade credit).

-   **Profitability & Efficiency:** **Gross margin \~28-30%** (distributor margins, ❌ &lt;40%). **Net margin \~7.8%** (recent TTM, and historically \~7-8%), ❌ below 20%. **ROE \~30%** (TTM 30.2% ) - far above 15% (✅). 10-year average ROE also &gt;20%. **ROIC \~21%** (3-yr avg \~21% per AlphaSpread ) - well above 12% (✅). **ROA \~10%** , passes 6% (✅). **Depreciation/Gross Profit** is low: distribution business doesn't need heavy capex - depreciation \~1-2% of gross profit (✅). These indicate Pool is **highly efficient**: it turns modest margins into high ROE through fast asset turnover and appropriate leverage.

> **Verdict:** Pool Corp is **an outstanding business (high ROE, high growth)** but was **purchased at a rich valuation**, so it fails the classic Buffett entry point tests (P/E, P/B, yield). Buffett's willingness to double his stake signals that he views Pool as a **long-term compounder** worth paying up for. It passes many qualitative marks: dominant market share (over 40% of pool supply distribution), secular tailwinds (aging pools need maintenance), and exceptional management. While Pool doesn't scream "value stock" in the Benjamin Graham sense, it embodies the **"wonderful company"** that Buffett is willing to own for decades. Its ratings on the checklist are a mix - fundamental quality ✅, but initial price ❌ - suggesting Buffett stretched his typical criteria for Pool, betting on its enduring **competitive advantage and earnings power**.

### **HEICO Corporation (HEI) -**

### **Aircraft Parts & Electronics**

###  **✅✈️**

-   **Valuation Discipline:** Heico is a **serial high-P/E stock**. Currently its **P/E is \~70+** (one of the highest in Buffett's portfolio), far above 15 (❌). **P/B** \~12× (equity \~$25/share vs price \~$300), ❌ way above 1.5. There's effectively **no margin of safety by traditional measures** - indeed, Alphaspread estimates Heico is \~41% *overvalued* relative to intrinsic value (❌). So on paper, Heico fails Buffett's typical valuation discipline in every way. The fact that Berkshire still bought (and added more) suggests this is an outlier where Buffett (or his deputies) made an exception, likely due to Heico's unique quality (perhaps expecting high growth to eventually "earn into" the valuation).

-   **Cash Generation & Allocation:** Heico generates **consistent free cash flow** thanks to its aftermarket parts business model. It has positive FCF each year (✅). **FCF/Revenue** tends to be solid: e.g. in FY2022, Heico's operating cash flow was $440M on $2.21B revenue (\~20%), capex \~$50M, so FCF \~17.6% of revenue - easily above 5% (✅). Heico reinvests via acquisitions and some internal R&D. **Return on retained earnings** seems good - Heico pays a tiny dividend and reinvests \~90% of earnings. Its ROE \~15.7% is not huge, but given minimal payout, that implies retained earnings yielding \~15%, above 12% (✅). Historically, Heico's strategy of continuous small acquisitions in niche aerospace/defense parts has yielded \~15+% earnings growth, indicating strong returns on reinvested capital (✅).

-   **Growth & Predictability:** Heico's **EPS growth** has been very steady (15% CAGR over decades) *except* **2020**where earnings dropped (\~-15% YoY) due to COVID grounding airlines (❌ for unbroken growth). It quickly resumed growth in 2021-2022. **Book value per share** has grown from \~$5 in 2013 to \~$19 in 2023 (\~14% CAGR) with no declines (✅). **Owner's earnings** (Heico's net income plus amortization minus capex) are positive every year (✅). But at the current lofty market cap, **OE yield is tiny**: Heico's \~$400M net income vs $40B market cap \~1% yield (❌). Clearly, investors are valuing Heico for future growth, not current yield - a violation of the typical ≥10% owners yield that Buffett likes.

-   **Balance-Sheet Safety:** Heico has a **moderate debt** profile. **Debt/Equity \~0.57** (57%) , slightly above 0.5 (❌). However, its interest expense is quite low (Heico deliberately keeps debt modest). **Interest coverage** is very strong: EBIT covers interest \~30× (EBIT \~$376M, interest \~$12M) (✅). **Interest expense/EBIT** \~3% (✅ easily under 15%). **Current ratio \~3.5** (Heico typically has plenty of liquidity, including cash, to support operations), so &gt;1.5 (✅). In sum, aside from D/E marginally over 0.5, Heico's balance sheet is **rock-solid** (lots of cash, low leverage).

-   **Profitability & Efficiency:** **Gross margin \~39-40%** (Heico's gross margin 39.3% in 2022 , \~42% in 2021), basically at the 40% mark (✅ borderline). **Net margin \~14.5%** (FY2022 net $334M on $2.30B rev) , below 20% (❌). **ROE \~15.7%** (TTM) , meets 15% (✅). 10-year avg ROE \~16% as well - solid. **ROIC \~8.9%** , which fails the ≥12% test (❌). This partly reflects that Heico carries a lot of goodwill from acquisitions, which depresses ROIC - its incremental returns on acquisitions are likely higher than 9%, but accounting makes ROIC look mediocre. **ROA \~7.4%** , passes &gt;6% (✅). **Depreciation/Gross Profit** is low: Heico has light capex; depreciation was \~$50M vs gross profit \~$900M in 2022 (\~5.5%), easily under 10% (✅).

> **Verdict:** By Buffett's normal standards, Heico **fails the valuation test completely** but **passes the quality test in many aspects**. It's a **high-moat niche business** (FAA-approved parts supplier with cost advantage vs OEMs) that has grown profitably for decades - characteristics Buffett loves. Yet its stock is priced for perfection, which is not Buffett's usual entry point. The decision to invest in Heico indicates Buffett's team made a rare exception, likely believing **Heico's long-term growth runway and competitive advantage justify paying up**. In checklist terms: business fundamentals ✅, but initial price ❌. Buffett might argue that **Heico is akin to a "inevitables"** (great businesses that will grow into any reasonable valuation), so he's willing to hold his nose on the P/E. In summary, Heico is a **wonderful company acquired at not-so-wonderful price**, making it an outlier in the portfolio (hence Berkshire's stake is relatively small).

### **Constellation Brands (STZ) -**

### **Beer, Wine & Spirits**

###  **🟡🍷**

-   **Valuation Discipline:** Constellation's valuation has been muddied by one-off losses. On a **normalized basis**, its P/E is \~18-20 (when excluding Canopy impairment, forward P/E \~18), slightly above 15 (❌). **P/B** is not meaningful: Constellation's equity is very low (after stock buybacks and writedowns, book value per share is barely positive \~$4, so P/B 40, ❌). **Margin of safety:** It's mixed. If we consider core operating earnings ($12 EPS) and a reasonable multiple, intrinsic value might be \~$200+, which is above the \~$170 stock price (maybe \~15% undervalued). However, including debt and uncertainties, the margin likely &lt;25%. So not a clear ✅. Buffett probably views STZ as fairly valued or slightly undervalued for a quality beverage business (⚠️ borderline).

-   **Cash Generation & Allocation:** Constellation generates **strong cash flow** from its alcohol businesses (beer in particular). It has positive FCF most years (✅). **FCF/Revenue** typically &gt;5% (e.g. FY2023 OCF $2.7B, capex $1.1B, on rev $9.5B, FCF \~17%) (✅). The company allocates cash to dividends and aggressive share buybacks (it retired \~20% of shares 2018-2023) as well as paying down debt from past acquisitions. **Return on retained earnings:** Historically decent - Constellation's retained earnings funded acquisitions like Modelo in 2013, which was hugely successful (ROI far &gt;12%). However, the large Canopy investment absorbed retained earnings and yielded a loss. Averaging out, Constellation's core business reinvestment (breweries, brand marketing) has been fruitful, but the cannabis misstep hurt returns. Arguably, if we separate that, the return on retained capital in core operations &gt;12% (core beer operating ROIC \~14%). We'll cautiously give a split score (core ✅, but overall tainted by write-off ❌).

-   **Growth & Predictability:** Constellation's **EPS growth** was stellar for many years (doubling from 2014-2018) but **has been volatile recently** (❌). EPS dropped in 2019 (Canopy equity losses), rebounded, then a GAAP loss in 2023 due to another write-down (two years of declines in 10, so fails predictability). Core operating EPS grew consistently sans those charges. **Book value per share** actually turned *negative* in 2018 (due to huge buybacks exceeding equity). Clearly fails the book growth criterion (❌ - book contracted to near zero). **Owner's earnings**remain positive (Constellation's operating earnings are strong), but **OE yield is moderate**: net income normalized \~$2B on a $30B market cap \~6.7% yield (❌ &lt;10%).

-   **Balance-Sheet Safety:** **Debt/Equity is very high** - actually not meaningful as equity is near zero (D/E can be seen as - Constellation's long-term debt \~$13B vs equity $0.5B, so D/E 26 if using tiny equity!). This is a **fail** (❌). More practically, **Net Debt/EBITDA \~4.0×** , which is on the high side for Buffett's comfort. They are deleveraging slowly. **Interest coverage** is acceptable: EBIT ($2.7B in 2022) vs interest ($500M) \~5.4× (✅ passes 3×). **Interest/EBIT** \~18.5% (just above 15%, ❌). **Current ratio \~1.3** (mid-2023, current assets $4.3B vs CL $3.3B), slightly below 1.5 (❌). So the balance sheet is leveraged, though manageable for a stable cash cow (Constellation carries debt from big acquisitions). Buffett generally shuns high leverage, so this is a negative mark.

-   **Profitability & Efficiency:** **Gross margin \~51-52%** (beer, wine have high gross margins), passes 40% (✅). **Net margin** excluding one-offs \~25% (Constellation's operating net margin \~25% in beer segment; but GAAP net margin was -4.4% last year due to charges). Normalized, it's \~20-25%, which would meet ≥20% (✅ on core basis). **ROE** can't be evaluated normally due to near-zero equity (ROE swung from +15% to -0.3% to hugely negative with losses) (❌ not meaningful). **ROIC** (core) \~10-11% , below 12% (❌). **ROA** \~9% (in 2023, avg assets \~$22B vs net $2B core profit) - above 6% (✅). **Depreciation/Gross Profit:** Constellation's depreciation \~$370M/year vs gross profit \~$4.9B (about 7.5%), which is ≤10% (✅).

> **Verdict:** Constellation Brands **only partially meets the Buffett great-company test**. On the positive side, it has **wide moats** (strong brands, distribution) and high margins. But its **balance sheet and recent earnings volatility** drag it down. Buffett likely invested because of the strength of Constellation's core beer business (Corona/Modelo, which throw off lots of cash) - a qualitative plus - despite the company's high debt and misadventure in cannabis (which are atypical of a classic Buffett play). In our checklist, STZ scores 🟡: **profitable with a solid core (✅)**, yet **overleveraged and not consistently growing (❌)**. Berkshire's continued buying indicates they expect the core earnings to shine through, and perhaps they trust management to rein in debt and focus on the lucrative alcohol segment going forward (making it closer to Buffett's ideal over time).

### **Domino's Pizza (DPZ) -**

### **Global Pizza Chain**

###  **🟡🍕**

-   **Valuation Discipline:** Domino's has usually traded at a premium. Its **P/E \~28-30×** in 2025 (❌ &gt;15). **P/B** is meaningless because Domino's has *negative book equity* (from massive buybacks), definitely not ≤1.5 (❌). **Margin of safety:** Not much - DCF analyses suggest Domino's was roughly at fair value around $450/share (perhaps a few percent undervalued at best, ❌). So Buffett did not get Domino's at a bargain price; it was more of a **quality-compounder purchase**. He only added slightly in Q2, reflecting that it wasn't a screaming deal.

-   **Cash Generation & Allocation:** Domino's is a **cash-generating franchise model**. It has **positive free cash flow every year** for over a decade (✅). **FCF/Revenue** is strong: \~10-15%. In 2022, FCF \~$150M on $4.5B revenue (\~3.3% - lower due to store investment and higher inventory in supply chain; but prior years \~10%+). Averaged out, FCF &gt;5% of sales (✅). Domino's uses cash primarily for **dividends and large share buybacks** (it has retired \~1/3 of its shares in 10 yrs). **Return on retained earnings:** Domino's doesn't retain much (it *returns more than 100%* of earnings via debt-fueled buybacks). It's actually *negative retained earnings* if anything. Despite that, EPS grew by \~15% CAGR (mostly from buybacks and some sales growth). So the concept of retained earnings yielding &gt;12% isn't directly applicable (they didn't retain, they leveraged). If we consider return on *invested capital* (by debt holders and equity), Domino's core business yields high returns, but its approach violates Buffett's usual preference for low debt. We mark this (❌) in classical terms, though one could argue their capital allocation (aggressive buybacks at reasonable prices) effectively boosted shareholder returns.

-   **Growth & Predictability:** **EPS growth has been very consistent** for Domino's. It increased EPS every year from 2009 through 2021, a remarkable run. **However, 2022-2023 broke the streak** - EPS in 2022 was slightly down (\~-7%) from 2021, and 2023 roughly flat, due to higher costs and slower sales (❌ on 10-year no declines). Still, long-term growth is intact. **Book value per share** is negative now and was shrinking even before (due to buybacks), definitely failing (❌ no 10-yr growth in equity - it went the opposite way). **Owner's earnings** are positive each year (net income + depreciation - maintenance capex; Domino's has light capex since franchisees fund new stores) (✅). But **OE yield is low**: net $490M in 2022 on $14B market cap at the time \~3.5% yield (❌). So Domino's is a low-yield, high-growth story.

-   **Balance-Sheet Safety:** **Debt/Equity is not meaningful** (equity is negative \~$-$ deficit, so D/E is extremely high by definition) (❌). Domino's has intentionally levered up (Net debt \~$5.2B, about 5× EBITDA). This is part of its capital strategy but fails Buffett's &lt;0.5 debt rule. **Interest coverage** is okay: EBIT \~$725M vs interest \~$150M \~4.8× (✅ &gt;3). **Interest/EBIT** \~20.7% (❌ above 15%). **Current ratio \~0.8** (Domino's runs negative working capital - franchisees pay quickly, it pays suppliers slower - so current liabilities &gt; current assets, which is normal for it) (❌). Buffett usually likes negative working capital, but on a strict test CR&lt;1.5 fails. Domino's model is stable enough to carry high debt, but purely on safety metrics, it falls short.

-   **Profitability & Efficiency:** **Gross margin \~28.5%** (franchise and supply chain business, fairly low gross margin, ❌ &lt;40%). **Net margin \~12.5%** , misses 20% (❌). **ROE** - not meaningful now (negative equity makes ROE huge negative or incalculable), but historically Domino's ROE was very high when equity was small positive (\~-∞ now, ❌ for formal check). **ROIC** (return on invested capital) excluding goodwill is strong (\~30%), but including goodwill/debt, maybe \~12-15%. 10-year average ROIC likely around mid-teens (roughly meets 12% ✅). **ROA \~31%** in 2022 (franchise model yields high ROA since assets are low), far above 6% (✅). **Depreciation/Gross Profit** low: Domino's depreciation \~$90M vs gross profit \~$1.27B (\~7%), under 10% (✅).

> **Verdict:** Domino's is a **phenomenal business (huge ROA, global brand)** but **flunks many of Buffett's traditional financial rules**mainly due to its capital structure (heavy debt, negative equity) and valuation. Buffett typically avoids companies that are this levered. However, Domino's consistent success in scaling internationally and its shareholder returns (stock up \~15× over 10 years) likely convinced Berkshire to take a bite. In our criteria, Domino's gets a 🟡 - **operationally excellent (high returns, consistent growth)**, but **financially engineered with high leverage and bought at no discount**. Berkshire's small position suggests they admire the business economics but are cautious (hence only a \~0.3% portfolio stake). Domino's illustrates Buffett's flexibility: he invested despite multiple ❌ marks, likely because the **franchise quality and growth prospects** outweighed the balance sheet concerns in this case.

### **Apple Inc. (AAPL) -**

### **Consumer Tech Giant**

###  **✅🍏**

### **(Trimmed but still Berkshire's top holding)**

*(While Apple wasn't a new buy, Buffett's decision to retain \~90% of it means it's effectively "re-tested" each quarter against his standards. Here's how Apple stands, which also explains why Buffett trimmed some shares.)*

-   **Valuation Discipline:** Apple's valuation has **expanded substantially**. Its **P/E ratio** is \~30× (forward \~28×), which is **double** Buffett's ≤15 target (❌). Its **P/B ratio** is enormous - over 40× (Apple's book value is now very small due to buybacks; at June 2025, book equity \~$63B vs market cap \~$3T, P/B \~48) (❌). **Margin of safety** is essentially absent at current prices - quite the opposite, many would say Apple trades above intrinsic value. Buffett himself acknowledged Apple at \~$180 might not offer his usual margin of safety . That is likely why he trimmed 7% of the position - taking some profit because Apple no longer hits the "on sale" mark (❌ on valuation now, though it was a huge bargain when he bought in 2016-2018).

-   **Cash Generation & Allocation:** Apple is an **astonishing cash generator**. It produces \~$90-100B in FCF annually (✅ every year positive). **FCF/Revenue** is extremely high - 26% in FY2022 (FCF $111B on $387B sales) , far above 5% (✅). Apple returns nearly all cash to shareholders via buybacks and dividends ($100B/year). **Return on retained earnings** is tricky - Apple doesn't "retain" earnings in the classic sense anymore; it returns effectively all (retained earnings on balance sheet have even shrunk as buybacks exceeded earnings at times). But looking historically: Apple's retained earnings from the 2000s onward fueled the most profitable product ecosystem ever, far exceeding 12% returns (✅). Now, Apple's ROE &gt;100% (due to tiny equity from buybacks), which is not a meaningful figure. In essence, Apple doesn't need to reinvest much internally to grow; it generates excess cash beyond its growth needs - the hallmark of a Buffett cash cow.

-   **Growth & Predictability:** Apple's earnings have been **growing overall but not strictly every single year** (❌ for the 10-year streak). In the past decade, Apple had a couple of slight EPS declines (e.g. 2016 EPS fell 10%, 2019 EPS fell 0.5% vs 2018). Generally, EPS has trended up (10-year EPS CAGR \~13%). **Book value per share** is not meaningful now (Apple's massive buybacks turned its shareholder equity negative in 2023). So clearly it fails "10-year book growth with no declines" (❌ - book has declined dramatically due to buybacks). **Owner's earnings**(essentially Apple's FCF) are huge and positive every year (✅). But **OE yield** at the $3T valuation is modest: $100B OE on $3T \~3.3% yield (❌ &lt;&lt;10%). This is a key reason Buffett trimmed - Apple's earnings yield has compressed as the stock rose, violating the margin-of-safety yield he prefers.

-   **Balance-Sheet Safety:** Apple's balance sheet is **very strong**, though in a different way. **Debt/Equity** is not meaningful since equity is negligible after buybacks (accounting D/E looks high or undefined, ❌ formally). But Apple has **net cash slightly above zero** (it has \~$110B debt vs \~$55B cash + $35B marketable securities, so net debt \~ $20B; effectively zero relative to cash flow). It easily covers interest. **Interest coverage** is enormous - EBIT covers interest \~20× or more. For example, FY2022 EBIT $119B vs interest \~$2.6B \~46× (✅). **Interest exp/Op income** \~2.2% (✅ way below 15%). **Current ratio \~0.94** (Sep 2022 CA $135B vs CL $143B) (❌). But Apple's negative working capital is by design (it gets paid upfront by customers and pays suppliers later), a sign of strength, not distress. So practically, Apple's financial position is extremely safe - tons of liquidity and cash flow (the formal D/E and CR metrics register ❌ only due to Apple's capital structure choices, not any solvency risk).

-   **Profitability & Efficiency:** Apple is **highly profitable**. **Gross margin \~46%** as of 2024 (up from \~38% in 2021 with growth of services) , comfortably above 40% (✅). **Net profit margin \~25%** (FY2024 net margin 25.3% ) - above 20% (✅). **ROE** is inflated by low equity but enormous - over 100% (would be ✅ if meaningful). Looking pre-buybacks, 5-yr avg ROE (2012-2016) was \~33%, easily &gt;15% (✅). **ROIC** (return on invested capital, counting debt but excluding cash) is also excellent - estimates put Apple's ROIC \~25-30%. (E.g. ROIC \~26% in 2022). That far exceeds 12% (✅). **ROA** consistently \~20-30% (25.3% in 2024 ) - well above 6% (✅). **Depreciation/Gross Profit**: Apple's depreciation was \~$11B in 2022 vs gross profit \~$170B (\~6.5%), under 10% (✅). In short, Apple's profitability metrics are **off the charts**, ticking all the boxes easily except those distorted by capital structure.

> **Verdict:** Apple as a business is **an absolute superstar (✅ in quality/profitability)**. It only **fails on valuation grounds** in Buffett's framework. In 2016, when Buffett first bought Apple, it had a P/E \~10 and huge margin of safety - a no-brainer. By 2025, after a 5× stock increase, Apple no longer offers a value bargain, which is why Buffett trimmed. But he's still holding the bulk because Apple remains a **"great company"** with unmatched cash flow and a powerful ecosystem (Buffett calls it "probably the best business I know in the world" and jokes he'd love if it got cheaper so he could buy more). So Apple is a case where Buffett holds a ✅✅✅ business even when it becomes ❌ on entry valuation, trimming at the margins but largely sticking with this modern golden goose.

### **Bank of America (BAC) -**

### **Large U.S. Bank**

###  **✅💰**

### **(Small trim in Q2; still a top-3 holding)**

-   **Valuation Discipline:** Bank of America's **P/E \~9-10×** (2025e earnings \~$3.80/share vs stock \~$29-30) - nicely under 15 (✅). **P/B ratio \~1.0-1.1** (BAC's book value per share \~$30.6, stock \~$29 in Aug 2025, P/B \~0.95) , under 1.5 (✅). **Margin of safety:** Banks are valued on book value and earnings power; at \~0.95× book and \~9× earnings, BAC appears moderately undervalued. Not a screaming 50% discount, but likely ≥25% undervalued relative to a fair P/E \~12 or P/B \~1.5 (✅). So BAC's valuation is very much in line with Buffett's discipline (one of the reasons he amassed such a large stake).

-   **Cash Generation & Allocation:** BofA consistently generates **positive free cash flow** (though for banks, FCF is not as clear due to loan/deposit flows). In terms of earnings, BAC has been solidly profitable every year since the financial crisis recovery (✅). **FCF/Revenue** not meaningful for banks; instead consider **Efficiency ratio** \~60% (meaning 40% operating margin). BofA returns cash via dividends and huge buybacks (it paid out \~100% of earnings to shareholders in recent years). **Return on retained earnings:** Banks retain earnings to build capital or buy back shares. BAC's ROE is \~11% in 2023, and it mostly paid out profits instead of retaining. Hard to measure directly, but BAC's retained earnings over the past decade rebuilt its book value and capital ratios, enabling growth in lending capacity. Now with less need to retain, it's returning capital. Historically, when BAC did retain earnings (2010s), it improved ROE from mid-single digits to low-double digits - arguably meeting \~12% return on incremental equity in that period (borderline ✅).

-   **Growth & Predictability:** **EPS growth** - BAC's EPS has grown overall in the last 10 years (from $0.90 in 2013 to \~$3.50 in 2022), but **there were down years** (❌). Notably 2020 saw EPS drop \~-40% (COVID loan loss provisions), though still positive. It's a cyclical pattern tied to credit cycles - fails "each year up." **Book value per share** grew from \~$20 in 2013 to \~$30.6 in 2023 (CAGR 4.3%). However, book value dipped slightly in 2020 (credit reserves) and in 2022 (as rising rates hit bond portfolio equity). So no perfect streak (❌). **Owner's earnings** (net income \~ $25-30B/year) positive every year (✅). **OE yield** \~ maybe 10% at current market cap ($25B on \~$230B mkt cap 10.9%) - in mid-2025 stock was higher ($47 in Benzinga list, though likely erroneous, actual \~$29; using actual: $25B NI on $230B \~10.9%) . So around the threshold (✅ borderline). BAC's earnings yield is one of the highest among big stocks Buffett owns.

-   **Balance-Sheet Safety:** **Debt/Equity** is not quite meaningful for a bank (banks use deposits and debt differently). But BAC's overall leverage (Assets/Equity \~7.5×) is standard for a bank, corresponding to \~D/E 6.5 if one counts deposits as debt. For a bank, this is normal (and within regulatory capital limits). Traditional D/E &lt;0.5 doesn't apply to banks (❌ if applied literally). Instead, consider **Common Equity Tier 1 (CET1) ratio \~11.6%** - healthy. **Interest coverage** - also not standard for banks (interest is a cost of goods sold for banks). Instead, look at **interest expense/interest income** - BofA easily covers interest on its debt with interest earned on loans. **Current ratio** - not used for banks; liquidity measured by other ratios. BofA's liquidity coverage ratio \~120% (ample). So by normal corporate metrics, it fails (❌), but by banking standards it's safe (Buffett evidently trusts BofA's balance sheet, especially after post-2008 reforms). BofA is the **safest large U.S. bank** per Buffett, given he held it through banking turmoil.

-   **Profitability & Efficiency:** **Gross margin** N/A for banks (they have net interest margin \~2.5%). **Net margin \~30%** (BAC's net income \~$27B on revenue \~$89B in 2022 \~30.3%) - above 20% (✅). **ROE \~11%** in recent years, below 15% (❌). Buffett prefers higher ROE, but banks today run lower ROEs due to higher capital requirements. Historically, BofA's ROE was \~15%+ pre-2008; post-crisis it's \~10-12%. **ROA \~1.1%** (2022 NI $27.5B on assets $2.5T) - *far below 6%* (❌, but banks never have ROA that high; 1% is good in banking). **ROIC**- not applicable in usual sense; for banks, ROE is main. **Depreciation** minimal relative to profit (banks' depreciation on branches etc. is negligible, intangible here).

> **Verdict:** Bank of America **meets Buffett's criteria in terms of value and acceptable performance**, though not on growth or asset-light returns. Buffett has often said banks won't have high ROE like before, but if bought cheap, they can still be great investments. BAC gets a ✅ for *valuation* and *adequate profitability*, but a ❌ on *predictability* and *Buffett's ideal high ROE*. Buffett's continued large holding implies he's satisfied that BAC is a well-run bank (CEO Brian Moynihan has his confidence) with a durable competitive advantage in deposit franchise. It's not a high-growth company, but it's a **stable, low-risk earner** that was acquired at a **compelling price** - very much in line with Buffett's value playbook.

### **T-Mobile US (TMUS) -**

### **Wireless Carrier**

###  **❌📱**

### **(Position exited)**

-   **Valuation Discipline:** T-Mobile's **P/E \~20×** in early 2025, above 15 (❌). It wasn't particularly cheap. **P/B** \~2.3× (equity \~$60B, mkt cap \~$140B) - &gt;1.5 (❌). No clear margin of safety - telecoms typically trade around 8-12× EBITDA; TMUS was at \~9× EV/EBITDA, more or less fair. So not a Buffett-style bargain (❌). Buffett likely held TMUS for non-valuation reasons (possibly arbitrage from the Sprint merger) and sold once fully valued.

-   **Cash Generation & Allocation:** T-Mobile generates decent FCF now that merger synergies are kicking in (positive FCF last few years). **FCF/Revenue \~5-6%** in 2022-23 (just passes 5%, ✅). However, T-Mobile is pouring cash into 5G network, so historically FCF was scant. They don't pay dividends yet but plan buybacks. **Return on retained** is unclear - so far, retained cash goes to capex more than earnings growth (❓). Not a strong story of high returns on equity - T-Mobile's ROE is modest \~6-8% post-merger.

-   **Growth & Predictability:** T-Mobile grew EPS nicely after 2020 (merger boosted profits), but prior to that, it was low-profit or in loss. **EPS is not a 10-year consistent rise** (losses in early 2010s) (❌). **Book value per share** has grown but had dilution from merger (❌ at least one down year or stagnation). **Owner's earnings** positive recent years, negative earlier (❌ not consistently positive for 10 yrs). **OE yield** \~2-3% (2023 FCF \~$6B on $180B market cap \~3.3%) (❌).

-   **Balance-Sheet Safety:** **Debt/Equity \~1.1** (post Sprint-merger, T-Mobile took on debt), ❌ above 0.5. **Interest coverage** \~4× (EBIT \~$7B vs interest \~$1.7B) - okay (✅). **Interest/EBIT** \~24% (❌ &gt;15%). **Current ratio \~0.8**(telcos have high current liabilities like device financing, ❌).

-   **Profitability & Efficiency:** **Gross margin \~61%** (mostly service margin, passes 40% ✅). **Net margin \~7%**(2022 net $2.6B on $79B rev \~3.3%; 2023 improved to \~7% with synergy) - well under 20% (❌). **ROE \~6-8%**since merger (❌ &lt;15%). **ROIC \~4-5%** (wireless is capital-intensive, ❌ &lt;12%). **ROA \~2%** (❌ &lt;6%). **Depreciation/Gross Profit** high (they depreciate billions in network assets; depreciation \~$11B vs gross profit \~$50B \~22%) (❌).

> **Verdict:** T-Mobile **failed many Buffett criteria**, especially profitability and stable growth. Its heavy capex, modest ROE, and lack of undervaluation made it an odd fit. Berkshire's sale of TMUS (100% exit) reflects that it didn't measure up as a long-term Buffett holding. It was likely a special situation investment that had run its course. In short, TMUS gets ❌ on Buffett's quality checklist, explaining why Berkshire liquidated the position.

### **Charter Communications (CHTR) -**

### **Cable Broadband**

###  **🟡💻**

### **(Holding halved in Q2)**

-   **Valuation Discipline:** Charter's stock had dropped such that **P/E \~13×** 2025e - under 15 (✅). **P/B** not meaningful (negative equity from buybacks, ❌). Hard to judge intrinsic value; some argue it was slightly undervalued mid-2025. But importantly, **Charter's debt load** ($90B) means enterprise-value based metrics were not low (EV/EBITDA \~7×, fair for cable). Margin of safety was questionable given industry challenges (⚠️ borderline). Buffett clearly decided any value gap wasn't sufficient to justify full position, hence selling \~46% of shares.

-   **Cash Generation & Allocation:** Charter generates **huge FCF** (it pioneered aggressive buybacks with FCF). **FCF/Revenue \~20%** (2022 $8B FCF on $45B rev) (✅). It retains almost no earnings (all FCF to buybacks). **Return on retained** is moot since they don't retain; but the effect was a shrinking share count and decent EPS growth - though now growth slowed. Possibly a neutral/⚠️.

-   **Growth & Predictability:** Charter's EPS grew fast 2016-2021 post-mergers, but **flattened in 2022-23** as cord-cutting hit (❌ not consistent). **Book value per share** went deep negative due to buybacks (❌). **Owner's earnings** positive (yes, FCF positive each year) (✅). **OE yield** respectable: $8B FCF on \~$100B market cap \~8% yield (just shy of 10%, ⚠️ borderline).

-   **Balance-Sheet Safety:** **Debt/Equity** meaningless (negative equity from $ buybacks, ❌). Charter's **Net debt/EBITDA \~4.5×**, which is quite high. **Interest coverage \~3×** (EBIT \~$8B vs interest \~$2.6B) - just meets threshold (✅ borderline). **Interest/EBIT** \~33% (❌ &gt;15%). **Current ratio \~0.3** (cable bills in advance, very low CA, ❌). Highly levered, which Buffett usually dislikes.

-   **Profitability & Efficiency:** **Gross margin \~62%** (cable broadband has high gross margin, ✅). **Net margin \~10%**(2022 net $5B on $54B rev \~9.3%, under 20% ❌). **ROE** not meaningful (negative equity, but if calc, huge negative). **ROIC** (\~7% on invested capital if including debt) (❌ below 12%). **ROA \~3%** (❌). **Depreciation/Gross Profit** high (cable network depreciation is big; in 2022 dep+amort $9.7B vs gross profit \~$25B \~39%) (❌ above 10%).

> **Verdict:** Charter **falls short on leverage and growth**, though it throws off cash. Buffett's partial sale likely indicates he's less confident in Charter meeting his quality benchmarks going forward (cord-cutting pressure, etc.). It's 🟡 trending ❌: a once attractive FCF machine that now faces strategic headwinds and carries too much debt for comfort.

### **(Others trimmed - Liberty Formula One (FWONK), DaVita (DVA), VeriSign (VRSN))**

### **:**

-   **FWONK:** A tracking stock for F1 racing - **low margins, heavy debt**. Buffett trimmed; likely ❌ on margin (barely profitable) and not a core holding.

-   **DaVita:** Kidney dialysis provider Buffett long held. It has **okay valuation (P/E \~13) and decent ROE (\~15%)**, but growth is challenged and debt is high (D/E \~1.2). Buffett's gradual selling implies it's borderline/❌ on some criteria (regulatory overhang, low growth).

-   **VeriSign:** A strong **moat business (high margin \~64%, ROE &gt; - due to buybacks)**, but Buffett's sale was to get below 10% ownership, not quality. VRSN actually **meets many criteria**: P/E \~28 (high, ❌), but net margin \~61% (✅!), FCF margin \~70%, no debt (✅), consistent cash flows (✅). If anything, VeriSign is a ✅ on quality but ❌ on valuation - Buffett's stake remains large, suggesting he still likes it, just needed to trim for regulatory reasons.

## **Conclusion:**

The latest Berkshire portfolio moves highlight Buffett's **unwavering commitment to value and quality.** He **added stocks that were trading at significant discounts** to their intrinsic worth (homebuilders, a steelmaker, an insurer), **in businesses that generally meet his standards** of strong cash flows and durable advantages. Conversely, he **lightened positions that had either become overvalued** (Apple's valuation soaring beyond his comfort) **or that no longer fit his quality or risk criteria** (telecom/cable with high debt and uncertain growth).

When we stack up the companies against Buffett's classic checklist, we see a pattern: **Almost none are perfect on every metric** - even Buffett bends the rules at times. But those he's buying tend to score well in the most crucial areas: *sound valuation, robust cash generation, and competitive durability*. The companies he's moving away from are the ones with **thin margins, heavy leverage, or unpredictable futures**, which violate the "great company" test in one way or another.

In summary, **Berkshire's Q2 2025 changes show a rotation from richly priced tech/telecom toward more traditional value plays**, in line with Buffett's mantra of being *"greedy when others are fearful"*. The detailed DCF analyses confirm that many new holdings offered **substantial upside to intrinsic value**, while the trims had less room to run. And our criterion-by-criterion review affirms that **Buffett remains focused on high-return, moat-worthy businesses**: almost every stock he added (despite minor weaknesses) has **strong fundamentals that largely align with his principles**, whereas those he reduced generally fell short of his benchmarks.

Buffett's strategy thus continues to be a **masterclass in balancing value and quality** - seeking out companies trading below their true worth *and* meeting most of his gold-standard business criteria, and pruning those that do neither. His latest portfolio moves tell a clear story: **he's positioning Berkshire for resilience and value in an uncertain market**, sticking with what has worked for decades - *buying great companies at good prices* , and avoiding the rest.

**Sources:** Berkshire Hathaway 13F filings and analysis ; Financial media reports on Q2 2025 portfolio changes ; Company financial data from SEC filings and analyst databases (valuation metrics, DCF valuations, and historical performance) ; Buffett's own comments and past letters for interpretative context.
